Evogene Financial Statements From 2010 to 2024
| EVGN Stock | ILA 599.80 0.20 0.03% |
Check Evogene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evogene's main balance sheet or income statement drivers, such as , as well as many indicators such as . Evogene financial statements analysis is a perfect complement when working with Evogene Valuation or Volatility modules.
Evogene |
Evogene Company Current Valuation Analysis
Evogene's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Evogene Current Valuation | 8.8 M |
Most of Evogene's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evogene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Evogene has a Current Valuation of 8.8 M. This is 99.94% lower than that of the Biotechnology sector and 99.81% lower than that of the Health Care industry. The current valuation for all Israel stocks is 99.95% higher than that of the company.
Evogene Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evogene's current stock value. Our valuation model uses many indicators to compare Evogene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evogene competition to find correlations between indicators driving Evogene's intrinsic value. More Info.Evogene is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Evogene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evogene's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Evogene Financial Statements
Evogene stakeholders use historical fundamental indicators, such as Evogene's revenue or net income, to determine how well the company is positioned to perform in the future. Although Evogene investors may analyze each financial statement separately, they are all interrelated. For example, changes in Evogene's assets and liabilities are reflected in the revenues and expenses on Evogene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Evogene. Please read more on our technical analysis and fundamental analysis pages.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. EVOGENE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 131 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Evogene Stock
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:Check out the analysis of Evogene Correlation against competitors. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.